The anti-interleukin-1 in type 1 diabetes action trial - background and rationale (vol 25, pg 321, 2009)

被引:0
|
作者
Pickersgill, Linda M. S.
Mandrup-Poulsen, Thomas R.
机构
关键词
D O I
10.1002/dmrr.1051
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
引用
收藏
页码:780 / 780
页数:1
相关论文
共 50 条
  • [42] No evidence of association of the PDCD1 gene with Type 1 diabetes (vol 24, pg 1473, 2007)
    Fawwaz, S.
    Nikamo, P.
    Toern, C.
    Landin-Olsson, M.
    Lernmark, A.
    Alarcon-Riquelme, M.
    Kockum, I
    DIABETIC MEDICINE, 2008, 25 (02) : 243 - 243
  • [43] Behavior Modeling and Simulation for Conflicts in Vehicles-Bicycles Mixed Flow (vol 1, pg 25, 2009)
    Yao, Danya
    Zhang, Yi
    Li, Li
    IEEE INTELLIGENT TRANSPORTATION SYSTEMS MAGAZINE, 2009, 1 (03) : 34 - 34
  • [44] A new therapeutic approach for type 1 diabetes: Rationale for GNbAC1, an anti-HERV-W-Env monoclonal antibody
    Curtin, Francois
    Bernard, Corinne
    Levet, Sandrine
    Perron, Herve
    Porchet, Herve
    Medina, Julie
    Malpass, Sam
    Lloyd, David
    Simpson, Richard
    DIABETES OBESITY & METABOLISM, 2018, 20 (09): : 2075 - 2084
  • [45] A randomized, double-blind trial on the bioavailability of two CoQ10 formulations (vol 1, pg 1, 2009)
    Evans, Malkanthi
    Baisley, Joshua
    Barss, Sonya
    Guthrie, Najla
    JOURNAL OF FUNCTIONAL FOODS, 2009, 1 (02) : 240 - 240
  • [46] EFFECTS OF A MULTIDOMAIN LIFESTYLE INTERVENTION ON TELOMERE LENGTH: THE FINGER TRIAL (vol 25, pg 1, 2018)
    von Blanckenburg, Pia
    Pan, Yiqi
    Heisig, Sarah
    Shedden-Mora, Meike
    Albert, Ute-Susan
    Hadji, Peyman
    Witzel, Isabell
    Barsky, Arthur
    Rief, Winfried
    Nestoriuc, Yvonne
    INTERNATIONAL JOURNAL OF BEHAVIORAL MEDICINE, 2019, 26 (01) : 108 - 108
  • [47] Serum uric acid as a predictor for development of diabetic nephropathy in type 1 diabetes: an inception cohort study (vol 58, pg 1668, 2009)
    Hovind, P.
    Rossing, P.
    Tarnow, L.
    Johnson, R. J.
    Parving, H-H
    DIABETES, 2010, 59 (10) : 2695 - 2695
  • [48] Genetic variant near IRS1 is associated with type 2 diabetes, insulin resistance and hyperinsulinemia (vol 41, pg 1110, 2009)
    Rung, Johan
    Cauchi, Stephane
    Albrechtsen, Anders
    Shen, Lishuang
    Rocheleau, Ghislain
    Cavalcanti-Proenca, Christine
    Bacot, Francois
    Balkau, Beverley
    Belisle, Alexandre
    Borch-Johnsen, Knut
    Charpentier, Guillaume
    Dina, Christian
    Durand, Emmanuelle
    Elliott, Paul
    Hadjadj, Samy
    Jarvelin, Marjo-Riitta
    Laitinen, Jaana
    Lauritzen, Torsten
    Marre, Michel
    Mazur, Alexander
    Meyre, David
    Montpetit, Alexandre
    Pisinger, Charlotta
    Posner, Barry
    Poulsen, Pernille
    Pouta, Anneli
    Prentki, Marc
    Ribel-Madsen, Rasmus
    Ruokonen, Aimo
    Sandbaek, Anelli
    Serre, David
    Tichet, Jean
    Vaxillaire, Martine
    Wojtaszewski, Jorgen F. P.
    Vaag, Allan
    Hansen, Torben
    Polychronakos, Constantin
    Pedersen, Oluf
    Froguel, Philippe
    Sladek, Robert
    NATURE GENETICS, 2009, 41 (10) : 1156 - 1156
  • [49] Risk Factors for Urinary Incontinence Among Women With Type 1 Diabetes: Findings From the Epidemiology of Diabetes Interventions and Complications Study (vol 73, pg 1203, 2009)
    Araco, F.
    Alvaro, R.
    Gravante, G.
    Sorge, R.
    Venturini, G.
    Piccione, E.
    UROLOGY, 2010, 75 (03) : 754 - 754
  • [50] Anti-viral action against type 1 diabetes autoimmunity: The GPPAD-AVAnT1A study protocol
    Hummel, Sandra
    Kaessl, Alexandra
    Arnolds, Stefanie
    Achenbach, Peter
    Berner, Reinhard
    Casteels, Kristina
    Hyoty, Heikki
    Kordonouri, Olga
    Larsson, Helena Elding
    Lundgren, Markus
    Marcovecchio, M. Loredana
    Owen, Catherine
    Pfirrmann, Markus
    Robson, Steve
    Szadkowska, Agnieszka
    Szypowska, Agnieszka
    Tree, Timothy
    Weiss, Andreas
    Ziegler, Anette-Gabriele
    Bonifacio, Ezio
    CONTEMPORARY CLINICAL TRIALS COMMUNICATIONS, 2025, 44